The international success of Leuconnect makes the platform grow.

Dutch is now added to the five languages already offered.

Clinical studies are multiplying on Leuconnect and the investigators involved show their satisfaction by renewing the conduct of their studies on the platform. Their experiences, as well as those of families, feed the evolution of the tool to better meet needs.

ELA International keeps the goal to providing access to online clinical studies to as many patients as possible.

Now the platform is accessible to patients directly in Dutch and investigators can also conduct their studies in this language.